1. Home
  2. NEO vs AKR Comparison

NEO vs AKR Comparison

Compare NEO & AKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • AKR
  • Stock Information
  • Founded
  • NEO 2001
  • AKR 1993
  • Country
  • NEO United States
  • AKR United States
  • Employees
  • NEO N/A
  • AKR N/A
  • Industry
  • NEO Precision Instruments
  • AKR Real Estate Investment Trusts
  • Sector
  • NEO Health Care
  • AKR Real Estate
  • Exchange
  • NEO Nasdaq
  • AKR Nasdaq
  • Market Cap
  • NEO 2.3B
  • AKR 2.6B
  • IPO Year
  • NEO 1999
  • AKR 1993
  • Fundamental
  • Price
  • NEO $16.53
  • AKR $23.88
  • Analyst Decision
  • NEO Strong Buy
  • AKR Buy
  • Analyst Count
  • NEO 10
  • AKR 4
  • Target Price
  • NEO $20.30
  • AKR $23.00
  • AVG Volume (30 Days)
  • NEO 756.1K
  • AKR 1.8M
  • Earning Date
  • NEO 02-18-2025
  • AKR 02-11-2025
  • Dividend Yield
  • NEO N/A
  • AKR 3.18%
  • EPS Growth
  • NEO N/A
  • AKR N/A
  • EPS
  • NEO N/A
  • AKR 0.10
  • Revenue
  • NEO $644,118,000.00
  • AKR $367,395,000.00
  • Revenue This Year
  • NEO $12.98
  • AKR N/A
  • Revenue Next Year
  • NEO $9.83
  • AKR $5.54
  • P/E Ratio
  • NEO N/A
  • AKR $229.38
  • Revenue Growth
  • NEO 12.06
  • AKR 7.51
  • 52 Week Low
  • NEO $12.77
  • AKR $16.10
  • 52 Week High
  • NEO $21.22
  • AKR $26.29
  • Technical
  • Relative Strength Index (RSI)
  • NEO 44.50
  • AKR 33.20
  • Support Level
  • NEO $17.24
  • AKR $24.84
  • Resistance Level
  • NEO $18.20
  • AKR $25.83
  • Average True Range (ATR)
  • NEO 0.70
  • AKR 0.50
  • MACD
  • NEO -0.28
  • AKR -0.21
  • Stochastic Oscillator
  • NEO 6.41
  • AKR 1.52

About NEO NeoGenomics Inc.

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company's portfolios are located primarily in metropolitan areas of the United States. The company operates through three segments: core portfolio, which consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon and generates the majority of total revenue; funds, which comprises the funds launched by the trust; and structured financing, which consists of notes receivable and related interest income.

Share on Social Networks: